Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-25

FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved Bayer's supplemental application to add ALEVE GELCAPS (naproxen sodium) as an additional formulation of naproxen products.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE GELCAPS (NAPROXEN SODIUM)
  • Naproxen Sodium Tablet (Naproxen Sodium)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)